News — August 3, 2021 — Wolters Kluwer, Health announced a multi-year agreement restoring its collaboration with the Congress of Neurological Surgeons (CNS), the leading organization dedicated to advancing neurosurgery through education and innovation. From January 2022, Wolters Kluwer will publish three specialist medical journals from the CNS portfolio, including its flagship publication Neurosurgeryone of the most cited neurosurgical journals in the world.
Expand readership globally
“As we chronicle the advancement of neurosurgical discoveries, working with Wolters Kluwer provides an exciting opportunity for our publications to have an even deeper impact in the field,” said Dr. Brian L. Hoh, President of the Congress of Neurological Surgeons. “Wolters Kluwer brings global leadership, advanced digital solutions, and expertise in medical society publishing to our journal portfolio that will help us more effectively deliver practice-changing knowledge to neurosurgeons around the world.”
“I look forward to working with Wolters Kluwer again. They have a long history with CNS and NEUROSURGERY® publications. We anticipate a seamless transition and a productive, fruitful relationship as we face new opportunities in biomedical publishing,” said Dr. Nelson M. Oyesiku, Editor-in-Chief of NEUROSURGERY Publications.
In keeping with CNS’s mission to be the go-to organization for neurosurgeons, trainees, and industry innovators in neurosurgical disease, Wolters Kluwer will focus on growing CNS journal readership globally. worldwide through access and distribution on Ovid®, the world’s most trusted medical research platform, among other channels, and on raising the expert status of journals in the field.
Provide innovative content in neurosurgery
“It is an honor to be selected by the Congress of Neurological Surgeons to once again serve as their journal editor and to contribute to their efforts to advance the global practice of neurosurgery,” said Greg Samios, President and Chief Director, Health Learning, Research & Practice at Wolters Kluwer. “Through our reinvigorated collaboration, we aim to maintain CNS’s position as an indispensable partner for professionals in the field and to expand access to innovative neurosurgical research and scientific discoveries.”
Beginning in 2022, Wolters Kluwer will release three titles from the CNS Neurosurgery Portfolio:
- Neurosurgery – Publishes the best research in clinical and experimental neurosurgery covering the latest developments in science, technology and medicine, and is considered the most comprehensive source of information in neurosurgery.
- Operative neurosurgery – Provides hands-on guidance through state-of-the-art surgical practice materials, including operative procedures, anatomy, instrumentation, devices, and technology.
- Neurosurgery Open – An online-only, fully open-access journal that provides an outlet for the publication of scientific articles dealing with clinical neurosurgery and experimental neurosurgery, such as case series, case reports and other information of interest to neurosurgeons.
To learn more about the Congress of Neurological Surgeons, please visit www.cns.org.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for clinicians, nurses, accountants, lawyers and the tax, finance, auditing, risk, compliance and regulation. We help our customers make critical decisions every day by delivering expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer achieved annual sales of €4.6 billion in 2020. The group serves customers in over 180 countries, maintains operations in over 40 countries and employs around 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes in healthcare. We support clinical efficiency, learning and research, clinical monitoring and compliance, and data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information visit www.wolterskluwer.com, follow us on TwitterFacebook, LinkedIn and YouTube.